I absolutely consider this site the most important tool I have for investing.more testimonials »
KaloBios Pharmaceuticals Announces Pricing of IPO Thursday, January 31, 2:11 PM ET
KaloBios Pharmaceuticals (KBIO) announced the pricing of its previously announced IPO of 8,750,000 shares of common stock at a price to the public of $8.00 per share, less underwriting discounts and commissions.
KaloBios has granted the underwriters a 30-day option to purchase up to 1,312,500 additional shares of common stock at the same price to cover over-allotments, if any. KaloBios' common stock will trade on the NASDAQ Global Market under the symbol "KBIO."
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.